Who is sponsoring NCT03486158?

NCT03486158 is sponsored by Helse Møre og Romsdal HF.

What drugs are being tested in NCT03486158?

Interventions in NCT03486158: CalproSmart™ system.

What condition does NCT03486158 study?

NCT03486158 studies Inflammatory Bowel Diseases.

Is NCT03486158 still recruiting?

NCT03486158 is currently completed. Last updated 13 April 2020.

Last reviewed 2020-04-13 · How we verify

NCT03486158

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The CalproSmartNOR Study - a New Clinical Tool for Monitoring Patients With Inflammatory Bowel Disease

Completed NA Last updated 13 April 2020

What this trial tests

NA trial testing CalproSmart™ system in Inflammatory Bowel Diseases in 109 participants. Completed in 27 March 2020.

Timeline

15 March 2018

Primary endpoint
27 March 2020

27 March 2020

Quick facts

Lead sponsor	Helse Møre og Romsdal HF
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	109
Start date	15 March 2018
Primary completion	27 March 2020
Estimated completion	27 March 2020
Sites	1 location across Norway

Drugs / interventions tested

CalproSmart™ system

Conditions studied

Inflammatory Bowel Diseases — all drugs for Inflammatory Bowel Diseases →

Sponsor

Helse Møre og Romsdal HF — full company profile →

Who can join

18 and older, any sex, with Inflammatory Bowel Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to prove that getting immediate calprotectin test results on the patients Smartphone (platforms such as Android or Iphone), will both stimulate patients with inflammatory bowel disease (IBD) to closer follow up of their disease, and that immediate automatic e-mails to a IBD-nurse will lead to earlier decision-making on further treatment and follow-up by health personnel (optimized medication, endoscopy etc).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Remote care through telehealth for people with inflammatory bowel disease.
Gordon M, Sinopoulou V, Lakunina S, Gjuladin-Hellon T, et al · · 2023 · cited 16× · PMID 37140025 · DOI 10.1002/14651858.cd014821.pub2

Verify or expand the search:

Other recruiting trials for Inflammatory Bowel Diseases

Currently open trials in the same condition.

NCT07520747 — A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea · recruiting
NCT07349472 — Pentoxifylline in Patients With Ulcerative Colitis · Phase 2 · recruiting
NCT07033208 — Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance · NA · recruiting
NCT06842316 — Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases · recruiting
NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting

Other Helse Møre og Romsdal HF trials

Trials by the same sponsor.

NCT07381790 — Modern Technologies in Lower Respiratory Tract Infections in Children · recruiting
NCT07021274 — DBT Skill Training for Autistic Adults With Difficulties in Emotion Regulation. · NA · not yet recruiting
NCT06458374 — ATTR Cardiac Amyloidosis in a Selected Population · recruiting
NCT06507046 — The personalKNEE Trial · NA · recruiting
NCT06499038 — The Ace Avanteon Study - A Randomized Controled Trial · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03486158 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Helse Møre og Romsdal HF
Last refreshed: 13 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03486158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing